#8 Clinical Trend: Contrave
Sales of Orexigen's Contrave, an antiobesity drug, have escalated quickly. Whereas a similar drug, Belviq, took 37 weeks to get over the 6,000 script mark, Contrave achieved that total in 9 weeks. Clearly, the booming popularity led health care providers to find out what all the fuss is about.
For more in-depth clinical information, see Obesity.
Medscape © 2015
Cite this: Ryan Syrek. Top 10 Clinical Trends for January 2015 - Medscape - Jan 27, 2015.